Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Neoplasms × sargramostim × Clear all

Phase

Phase 2 5 Phase 1/2 2 Phase 1 2 Phase NA 1 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 CNS 1

Conditions

Neuroblastoma 4 Leukemia 4 Leukemia, Myeloid, Acute 3 Sarcoma 2 Rhabdomyosarcoma 2 Melanoma 2 Malignant mesenchymal tumor 2 Lymphoma 2 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2 Breast Neoplasms 2 Uveal Melanoma 1 Urinary Bladder Neoplasms 1 Tongue Neoplasms 1 Stomatitis 1 Radiation Injuries 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pathologic Complete Response 1 Pancreatic Neoplasms 1 Neoplasms, Plasma Cell 1 Neoplasms 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Follicular 1 Leukemia, Promyelocytic, Acute 1 Leukemia, Myelomonocytic, Acute 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Monocytic, Acute 1 Leukemia, Megakaryoblastic, Acute 1 Leukemia, Erythroblastic, Acute 1

Interventions

Paclitaxel 19 Dexamethasone 16 Bevacizumab 16 Oxaliplatin 14 Docetaxel 14 Capecitabine 12 Gemcitabine 11 Cyclophosphamide 11 Sorafenib 10 Leucovorin 10 Fluorouracil 10 Carboplatin 10 Epoetin Alfa 9 pembrolizumab 8 Pemetrexed 8 Fentanyl 8 venetoclax 7 atezolizumab 7 Rivaroxaban 6 Prednisone 6 Ondansetron 6 Morphine 6 Irinotecan 6 Drug Therapy 6 Doxorubicin 6 Denosumab 6 Cisplatin 6 Tranexamic Acid 5 Sodium Chloride 5 Panitumumab 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01480479 2018-01-16

ACT IV

Celldex Therapeutics

Phase 3 Completed

Brain Neoplasms, Glioblastoma, Neoplasms, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡